Related Experiment Video

Updated: Jul 15, 2025

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

3.7K

Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain

Daniel Stone1, Martine Aubert1, Keith R Jerome1,2

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Molecular Therapy. Methods & Clinical Development
|September 27, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
09:59

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

2.7K
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

59.6K

Related Experiment Videos

Last Updated: Jul 15, 2025

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

3.7K
AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
09:59

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

2.7K
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
10:15

Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction

Published on: September 15, 2014

59.6K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.5K
Overview
47.5K

Articles linked to this work by shared authors, journal, and citation graph.

Susceptibility of clinical isolates, laboratory-adapted and drug-resistant herpes simplex virus strains to helicase-primase inhibitor adibelivir (IM-250) and its synergy in combination therapy with acyclovir, penciclovir and foscarnet.

Antiviral research·2026

Distinct Transcriptomic Profiles in ART-Treated People with HIV Are Associated with NF-κB-regulated Gene Expression and Inflammatory Cytokine Signatures.

Journal of acquired immune deficiency syndromes (1999)·2026

Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy.

Communications medicine·2026

In vivo HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention.

Molecular therapy. Advances·2026

Regulatory T cells restrain IL-15-mediated cytotoxic and bystander T cell activity in mucosal tissue without compromising antigen-driven memory.

bioRxiv : the preprint server for biology·2026

Kinetics of the O2 Reactions with CH3OCO and CH2OCHO Formed from Methyl Formate.

The journal of physical chemistry. A·2026

Characterization and quantitation of baculoviral DNA in rAAV vectors produced in Sf9 cells.

Molecular therapy. Methods & clinical development·2026

In vivo delivery of a fluorogenic antisense oligonucleotide into human leukocytes in a humanized mouse model system.

Molecular therapy. Methods & clinical development·2026

Development of high-throughput analytical methods for characterization and quantitation of rAAV genome integrity.

Molecular therapy. Methods & clinical development·2026

Morphological changes induced by buffer exchange during preparation of mRNA-lipid nanoparticles occur in a stepwise manner as pH is elevated.

Molecular therapy. Methods & clinical development·2026

Targeted inhibition of ELANE expression using adenine base editing to treat severe congenital neutropenia.

Molecular therapy. Methods & clinical development·2025

AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administration.

Molecular therapy. Methods & clinical development·2025

Multi-Omics Genome-Wide to Explore the Formation and Development Targets for Intracranial Aneurysms.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Triggering SORL1 Expression Restricts ccRCC Progression by Inducing Ubiquitination-Mediated c-Myc Degradation.

Cancer science·2026

FIN56-induced ferroptosis suppresses the development of endometriosis by augmenting mitochondrial ROS and lipid peroxidation via the ACACA/ARID5A/NOX4 axis.

Chinese medical journal·2026

Regulatory and Quality Considerations of Antibody-drug Conjugates.

AAPS PharmSciTech·2026

HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.

Nature communications·2026

Dual HBV cccDNA-linked HiBiT reporter hepatocyte models for screening of candidate cccDNA modulators.

Virulence·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us